Lee Ainslie Emergent Bio Solutions Inc. Transaction History

Maverick Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $193,958 - $322,248	-5,858 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $278,839 - $367,832	5,569 Added 1926.99%	5,858 $293,000
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $16,360 - $23,252	289 New	289 $18,000
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $203,847 - $295,949	-2,364 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $187,157 - $263,515	2,364 New	2,364 $212,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.